Medtronic PLC (NYSE:MDT) had declared a cash dividend of $0.4300 on Jun 24, 2016. The shares will quote ex-dividend on Jul 6, 2016 and the record date has been fixed for Jul 8, 2016. On Jun 24, 2016 share price, the yield comes out to be 2.0054%. The dividend payable date has been fixed on Jul 27, 2016.
In a different note, On Jun 13, 2016, SunTrust Robinson Humphrey said it Maintains its rating on Medtronic PLC. In the research note, the firm Raises the price-target to $93.00 per share. The shares have been rated ‘Buy’ by the firm. Guggenheim Securities said it Initiates Coverage on Medtronic PLC, according to a research note issued on Jun 9, 2016. The shares have been rated ‘Neutral’ by the firm. On Jun 2, 2016, Deutsche Bank said it Maintains its rating on Medtronic PLC. In the research note, the firm Raises the price-target to $90.00 per share. The shares have been rated ‘Buy’ by the firm. On Jun 1, 2016, BTIG Research said it Downgrades its rating on Medtronic PLC. In the research note, the firm Removes the price-target to $82.00 per share. The shares have been rated ‘Neutral’ by the firm. SunTrust Robinson Humphrey said it Initiates Coverage on Medtronic PLC, according to a research note issued on Apr 25, 2016. The shares have been rated ‘Buy’ by the firm.
Medtronic PLC (MDT) made into the market gainers list on Wednesdays trading session with the shares advancing 1.56% or 1.31 points. Due to strong positive momentum, the stock ended at $85.45, which is also near the day’s high of $85.729. The stock began the session at $84.34 and the volume stood at 51,21,235 shares. The 52-week high of the shares is $86.31 and the 52 week low is $55.54. The company has a current market capitalization of $153,899 M and it has 1,80,10,43,300 shares in outstanding.
Medtronic PLC(MDT) last announced its earnings results on May 31, 2016 for Fiscal Year 2016 and Q4.Company reported revenue of $7.57B. Analysts had an estimated revenue of $7.48B. Earnings per share were $1.27. Analysts had estimated an EPS of $1.27.
Several Insider Transactions has been reported to the SEC. On Jun 7, 2016, Richard Kuntz (SrVP & Chief Scien, Clin, Reg) sold 49,905 shares at $82.60 per share price.Also, On Jun 3, 2016, Hoedt Rob Ten (EVP & President EMEAC) sold 12,100 shares at $80.54 per share price.On Mar 22, 2016, Shirley A Jackson (director) sold 1,238 shares at $75.60 per share price, according to the Form-4 filing with the securities and exchange commission.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.